Signal
Neuromodulation Emerges as PMDD Clinical Priority Amidst Limitations of Hormonal and SSRI Therapies
- Category
- · Conversation · Global
- Date
- August 28, 2026
- Source
- OVUM
Summary
Neuroscientist Dr. Emilė Radytė highlights that PMDD stems from the brain's sensitivity to hormone fluctuations rather than chemical imbalances, positioning neurological interventions as a critical alternative to standard-of-care antidepressants and contraceptives.
Filed under Sexual & Reproductive and Care Delivery. Read it next to other recent activity in the same area.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- OVUM Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.